Antibody-drug conjugate effective, less toxic for stage 1 HER2+ breast cancer

A year of treatment with a medicine made of an antibody and chemotherapy drug has proven highly effective in preventing stage 1 HER2-positive breast cancer from recurring in patients, a team led by Dana-Farber Cancer Institute researchers has found.


http://dlvr.it/T8tCqd

Comments

Popular posts from this blog

Healthy Habits For A Strong Immune System

GLP-1 Drugs Before Bariatric Surgery Can Help People With Extreme Obesity

Understanding Digestive Disorders: Causes, Symptoms, And Treatment Options